Wentworth Kerry
- SEC CIK
- 0001369453
In the past year, 3 open-market sale filings worth $1.47M and no purchases.
Current role at each company
- NUVB Nuvation Bio Inc.CHIEF REGULATORY OFFICERas of Jun 24, 2026
- FLXN Flexion Therapeutics IncChief Regulatory Officeras of Nov 19, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.47M
- 3 filings
- Net
- −$1.47M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Wentworth Kerry as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NUVB Nuvation Bio Inc.
CHIEF REGULATORY OFFICER4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2026 (view filing) | Jun 23 | 1 day | Wentworth KerryCHIEF REGULATORY OFFICER | SSaleClass A Common Stock | −63.0K | $6.02 | −$379.3K | −54.3%53.0K after | 10b5-1 |
| Apr 21, 2026 (view filing) | Apr 17 | 4 days | Wentworth KerryCHIEF REGULATORY OFFICER | SSaleClass A Common Stock | −36.8K | $5.01 | −$184.1K | −40.9%53.0K after | 10b5-1 |
| Apr 8, 2026 (view filing) | Apr 6 | 2 days | Wentworth KerryCHIEF REGULATORY OFFICER | SSaleClass A Common Stock | −200.0K | $4.52 | −$904.0K | −79.1%53.0K after | 10b5-1 |
| Jun 18, 2025 (view filing) | Jun 16 | 2 days | Wentworth KerryCHIEF REGULATORY OFFICER | PPurchaseClass A Common Stock | +50.0K | $1.79 | +$89.7K | New position50.0K after | 2 lots |
FLXN Flexion Therapeutics Inc
Chief Regulatory Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 (view filing) | Jul 19 | 1 day | Wentworth KerryChief Regulatory Officer | SSale | −3.94K | $6.45 | −$25.4K | −2.7%140.4K after |